Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Infinera | INFN | 22. nov 2024 | 6.64 | +0.45 |
InflaRx N.V | IFRX | 22. nov 2024 | 2.08 | +0.97 |
Inflection Point Acquisition II | IPXX | 22. nov 2024 | 10.70 | -0.14 |
Inflection Point Acquisition II Unit | IPXXU | 22. nov 2024 | 10.86 | 0.00 |
Infobird | IFBD | 22. nov 2024 | 1.84 | +3.95 |
Informatica | INFA | 22. nov 2024 | 26.36 | -0.34 |
Information Services Group | III | 22. nov 2024 | 3.53 | +5.85 |
Information Technology ETF Vanguard | VGT | 22. nov 2024 | 621.58 | +0.37 |
Infosys ADR | INFY | 22. nov 2024 | 22.79 | +3.78 |
InfuSystems | INFU | 22. nov 2024 | 9.33 | +0.97 |
ING Group ADR | ING | 22. nov 2024 | 15.28 | -2.30 |
Ingersoll Rand | IR | 22. nov 2024 | 104.00 | +0.93 |
Ingevity | NGVT | 22. nov 2024 | 48.56 | +0.31 |
Ingles Markets A | IMKTA | 22. nov 2024 | 72.18 | +2.63 |
Ingram Micro Holding Corp | INGM | 22. nov 2024 | 22.00 | 0.00 |
Ingredion | INGR | 22. nov 2024 | 146.47 | +1.46 |
Inhibikase Therapeutics | IKT | 22. nov 2024 | 2.31 | +14.93 |
Inhibrx Biosciences | INBX | 22. nov 2024 | 14.08 | +0.72 |
InMed Pharmaceuticals | INM | 22. nov 2024 | 4.66 | +0.22 |
InMode | INMD | 22. nov 2024 | 19.02 | +2.89 |
INmune Bio | INMB | 22. nov 2024 | 4.87 | +2.31 |
Innate Pharma ADR | IPHA | 22. nov 2024 | 1.63 | -4.12 |
Inno Holdings | INHD | 22. nov 2024 | 4.96 | -1.98 |
Innodata | INOD | 22. nov 2024 | 44.77 | -3.16 |
Innospec | IOSP | 22. nov 2024 | 119.75 | +1.19 |
InnovAge | INNV | 22. nov 2024 | 4.89 | +5.62 |
Innovate | VATE | 22. nov 2024 | 5.99 | +24.27 |
Innovation Beverage Group | IBG | 22. nov 2024 | 1.11 | 0.00 |
Innovative Eyewear | LUCY | 22. nov 2024 | 6.56 | -2.38 |
Innovative Industrial Properties | IIPR | 22. nov 2024 | 107.12 | +1.28 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.